Phlorotannin-Rich Ascophyllum nodosum Seaweed Extract Inhibits Influenza Infection
Viruses · 2024
DOI: 10.3390/v16121919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Daniele F Mega und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK. Hauptthemen laut MEDLINE: Antiviral Agents, Ascophyllum, Seaweed, Orthomyxoviridae Infections. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Biotechnology and Biological Sciences Research Council (BBSRC) doctoral training partnership (DTP).
Abstract (Originalsprache)
Seaweed-derived compounds are a renewable resource utilised in the manufacturing and food industry. This study focuses on an enriched seaweed extract (ESE) isolated from Ascophyllum nodosum. The ESE was screened for antiviral activity by plaque reduction assays against influenza A/Puerto Rico/8/1934 H1N1 (PR8), A/X-31 H3N2 (X31) and A/England/195/2009 H1N1 (Eng195), resulting in the complete inhibition of infection. Time of addition assays and FACS analysis were used to help determine the modes of action. The therapeutic potential of ESE was then explored using differentiated human bronchiole epithelial cells at the air–liquid interphase and a murine model challenged with IAV. The data indicates that ESE primarily interacts directly with virions, reducing mean virus–cell binding by 79.3% with 0.01 mg/mL ESE. Interestingly, ESE also inhibits the early and late stages of the influenza A lifecycle when treatment occurs after cell binding. This inhibitory effect appears to reduce the internalisation of the virus and the release of progeny virus by targeting neuraminidase activity, with IC50 values of 0.5 μg/mL for X31, 3.2 μg/mL for Eng195 and 12.8 μg/mL for PR8. The intranasal administration of 5 mg/kg ESE in mice infected with IAV reduced the viral load in lung tissue. ESE may be a promising broad-acting antiviral agent in the treatment of influenza infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.
- Laboratory for Animal Model Pathology, Institute of Veterinary Pathology, University of Zurich, 8057 Zürich, Switzerland.
- Byotrol Technology Limited, Thornton Science Park, Chester CH2 4NU, UK.
ORCID-Profile: Daniele F Mega, Parul Sharma, Anja Kipar, Udo Hetzel, Chloe Bramwell, Richard A Urbanowicz, James P Stewart
Förderung
- Biotechnology and Biological Sciences Research Council
- Biotechnology and Biological Sciences Research Council (BBSRC) doctoral training partnership (DTP)
Zitieren
APA
Mega, D. F., Sharma, P., Kipar, A., Hetzel, U., Bramwell, C., Merritt, A., Wright, S., Plummer, C., Urbanowicz, R. A., & Stewart, J. P. (2024). Phlorotannin-Rich Ascophyllum nodosum Seaweed Extract Inhibits Influenza Infection. Viruses. https://doi.org/10.3390/v16121919
Vancouver
Mega DF, Sharma P, Kipar A, Hetzel U, Bramwell C, Merritt A, et al. Phlorotannin-Rich Ascophyllum nodosum Seaweed Extract Inhibits Influenza Infection. Viruses. 2024. doi:10.3390/v16121919
BibTeX
@article{Mega2024,
author = {Mega, Daniele F and Sharma, Parul and Kipar, Anja and Hetzel, Udo and Bramwell, Chloe and Merritt, Alan and Wright, Samuel and Plummer, Chris and Urbanowicz, Richard A and Stewart, James P},
title = {Phlorotannin-Rich Ascophyllum nodosum Seaweed Extract Inhibits Influenza Infection},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16121919}
}
EUVIMED